Skip to main content

Table 1 LV functional analysis

From: Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis

 

Control

Day 14

Day 21

LVEF (%)

66 (6)

65 (8)

47 (16) †

LVM (mg)

345 (33)

348 (72)

545 (156) *

LVM/BW (mg/g)

1.46 (0.27)

2.22 (0.54) †

3.01 (0.99) †

LVEDV (μl)

361 (34)

245 (37) †

309 (22) †

LVEDV/BW (μl/g)

1.52 (0.24)

1.56 (0.22)

1.69 (0.15)

LVESV (μl)

121 (16)

86 (17) †

163 (55)

LVESV/BW (μl/g)

0.50 (0.02)

0.54 (0.13)

0.90 (0.33) †

BW (g)

239 (25)

158 (14) †

183 (15) †

  1. LV function was analyzed on cine CMR. Mean (SD) of LVEF, LVM, LVM/BW, LVEDV, LVEDV/BW, LVESV, LVESV/BW, and BW of the control, early phase (day 14), and peak phase (day 21) groups are shown. [BW = body weight. Statistical analysis; * p = 0.01, †p < 0.01 compared to the control.] LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVM, left ventricular mass